AtriCure Q2 2024 GAAP EPS $(0.17), Inline, Sales $116.30M Beat $116.18M Estimate
Portfolio Pulse from Benzinga Newsdesk
AtriCure (NASDAQ: ATRC) reported Q2 2024 GAAP EPS of $(0.17), meeting analyst expectations. The company also reported sales of $116.30 million, slightly beating the $116.18 million estimate and marking a 15.24% increase from the same period last year.
July 30, 2024 | 8:04 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
AtriCure reported Q2 2024 GAAP EPS of $(0.17), meeting analyst expectations. Sales of $116.30 million slightly beat estimates and increased 15.24% YoY.
The company's earnings per share met expectations, and sales slightly beat estimates while showing significant year-over-year growth. This positive performance is likely to have a favorable short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100